$1.14
-0.05[-4.20%]
At close: May 17
$1.14
0[0.00%]
After Hours: 6:26PM EDT
Biodexa Pharmaceuticals
(NASDAQ:BDRX)Latest News for Biodexa Pharmaceuticals Stock (NASDAQ:BDRX)
Biodexa Pharmaceuticals Stock (NASDAQ: BDRX)
Categories: All
Monday, April 29, 2024
Friday, April 26, 2024
- Dow Surges Over 200 Points; Microsoft Shares Gain Following Upbeat EarningsAvi Kapoor - Apr 26, 2024, 2:50PM
- Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Apr 26, 2024, 1:56PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Apr 26, 2024, 12:31PM
- S&P 500 Gains 1%; Exxon Mobil Posts Downbeat EarningsAvi Kapoor - Apr 26, 2024, 12:06PM
- US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 PointsAvi Kapoor - Apr 26, 2024, 9:54AM
- Biodexa Pharmaceuticals Shares Resume TradeBenzinga Newsdesk - Apr 26, 2024, 9:38AM
- Biodexa Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 104.2%Benzinga Newsdesk - Apr 26, 2024, 9:33AM
- Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.Benzinga Newsdesk - Apr 26, 2024, 8:36AM
- Biodexa Enters Into Exclusive License To eRapa, A Phase 3 Ready Asset For The Treatment Of Familial Adenomatous Polyposis; Worldwide Rights Come With $17M In Non-Dilutive Grant Funding For Pivotal Phase 3 Trial In FAPBenzinga Newsdesk - Apr 26, 2024, 8:34AM
Friday, April 19, 2024
- Biodexa Pharmaceuticals Sees Prelim. FY23 EPS £(0.02)Benzinga Newsdesk - Apr 19, 2024, 8:14AM
- Biodexa Pharmaceuticals Says We Have The Resources To Deliver Two Sets Of Preclinical Data And Three Sets Of Clinical Data In 2024; Our Development Pipeline Now Includes Five Programs, Of Which Four Are At Clinical Stage; With Pipeline Stronger Than It Has Ever Been, We Are Enthusiastic About The Potential For Our Company In 2024 And Beyond.Benzinga Newsdesk - Apr 19, 2024, 8:09AM
- Biodexa Pharmaceuticals Sees Prelim. FY23 Revenue £0.38MBenzinga Newsdesk - Apr 19, 2024, 8:07AM
Wednesday, April 03, 2024
Friday, March 29, 2024
Thursday, March 28, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Mar 28, 2024, 4:31PM
- Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 ResultsAvi Kapoor - Mar 28, 2024, 2:56PM
- Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 28, 2024, 2:08PM
- Extend Life Expectancy Against Aggressive Brain Cancers - Nano-Cap Firm Biodexa's Investigational Drug Shows PotentialVandana Singh - Mar 28, 2024, 12:43PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 28, 2024, 12:31PM
- Gold Gains 1%; Walgreens Narrows Earnings ForecastAvi Kapoor - Mar 28, 2024, 12:30PM
- US Stocks Flat; Initial Jobless Claims Fall To 210,000Avi Kapoor - Mar 28, 2024, 10:32AM
- Market-Moving News for March 28thBenzinga Newsdesk - Mar 28, 2024, 8:36AM
- Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers; Shares Spike HigherBenzinga Newsdesk - Mar 28, 2024, 8:19AM
Tuesday, March 26, 2024
Monday, March 18, 2024
Friday, February 23, 2024
Wednesday, February 14, 2024
Tuesday, February 13, 2024
- Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 13, 2024, 1:13PM
- Why Is Brain Cancer Focused-Biodexa Pharmaceuticals Stock Trading Higher Today?Vandana Singh - Feb 13, 2024, 12:12PM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Feb 13, 2024, 8:06AM
- Biodexa Pharmaceuticals Up 151% Premarket; Bigger Capital Fund, Reported A 9.9% Stake In A 13G Filing On MondayCharles Gross - Feb 13, 2024, 5:22AM
Thursday, February 08, 2024
Wednesday, February 07, 2024
Tuesday, December 19, 2023
- Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares PlungeAvi Kapoor - Dec 19, 2023, 2:24PM
- Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Dec 19, 2023, 1:34PM
- Dow Jumps 150 Points; FactSet Shares Rise After Q1 ResultsAvi Kapoor - Dec 19, 2023, 12:54PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Dec 19, 2023, 12:32PM
- Biodexa Pharmaceuticals shares are trading lower after the company announced the pricing of a $5.2 million underwritten public offering of 697,614 units at $2.20 per unit.Benzinga Newsdesk - Dec 19, 2023, 12:12PM
- Why Biodexa Pharmaceuticals (BDRX) Shares Are Getting HammeredHenry Khederian - Dec 19, 2023, 9:43AM
- Biodexa Announces Pricing Of $5.2M Underwritten Public Offering Of 697,614 Units At $2.20/UnitBenzinga Newsdesk - Dec 19, 2023, 8:45AM